The granting of a patent typically signifies a competitive edge in technology and innovation, potentially leading to new products or services. For SiNtx Technologies, this Australian patent could pave the way for the development and commercialization of new antipathogenic products, thereby potentially increasing the company's market share and revenue in the long term. Investors might view this news as a positive development, reflecting the company's ongoing commitment to innovation and its ability to protect its intellectual property, which could lead to a short-term positive sentiment towards SINT's stock.